CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company
ATOSSA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATOS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264753208
- Phone
- 206.588.0256
- Business address
- 1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
- Former names
- ATOSSA GENETICS INC
- EFFECT Other Notice of Effectiveness
- DEF 14A Proxy Proxy Statement
- D Other Notice of Sales of Unregistered Securities
- S-1 Offering Registration Statement
- 10-K Report Annual Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Other events
- 8-K Event Unregistered share sale
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 10-Q/A Report 10-Q/A
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 4,000 shares at an average $4.12 ($16,460)
- 8-K Event Material agreement · Agreement ended · Executive or director change
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 29 of 33 · 643 filings